颅咽管瘤患者随访16年的骨折、骨密度与最终身高
这项回顾性横断面研究纳入177例颅咽管瘤患者(中位随访16年),评估骨折、双X线吸收法骨密度与最终身高。骨折发生于31例(18%),男性多于女性(26% vs 8%,P=.002)。平均骨密度Z值正常,但50%患者T或Z值≤-1,24%患者T值≤-2.5或Z值≤-2.0。作者认为极低骨密度似乎不是骨折风险的良好预测因素。
要点
- 颅咽管瘤患者骨折发生率为18%,男性26%高于女性8%(P=.002)。
- 男性接受低骨密度治疗的比例低于女性(7% vs 18%,P=.02)。
- 极低骨密度(T值≤-2.5或Z值≤-2.0)似乎不是骨折风险的良好预测因素(OR 2.1,P=.21)。
核心结论
- 颅咽管瘤男性患者骨折风险高于女性。
- 在颅咽管瘤患者中,极低骨密度(T值≤-2.5或Z值≤-2.0)似乎不是骨折风险的良好预测因素。
研究设计与样本
- 回顾性横断面研究,纳入荷兰与瑞典转诊中心的177例颅咽管瘤患者,中位随访16年(范围1-62年)。
- 177例中荷兰106例(60%),男性93例(53%),儿童期起病84例(48%)。
主要发现
- 骨折发生于31例(18%),男性多于女性(26% vs 8%,P=.002)。
- 平均骨密度正常(全身Z值0.1,范围-4.1至3.5),但47例(50%)患者T或Z值≤-1,22例(24%)患者T值≤-2.5或Z值≤-2.0。
- 男性接受低骨密度治疗的比例低于女性(7% vs 18%,P=.02)。
- 女性(OR 0.3,P=.004)和手术(OR 0.2,P=.01)均为骨折的独立保护因素,抗癫痫药物为危险因素(OR 3.6,P=.03),而T值≤-2.5或Z值≤-2.0不是(OR 2.1,P=.21)。
- 平均最终身高正常,男女之间及成人起病与儿童期起病患者之间无差异。
关键数值与推荐
- 低骨密度定义为T值或Z值≤-1;极低骨密度定义为T值≤-2.5或Z值≤-2.0。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Pituitary hormonal deficiencies in patients with craniopharyngioma may impair their bone health. OBJECTIVE: To investigate bone health in patients with craniopharyngioma. DESIGN: Retrospective cross-sectional study. SETTING: Dutch and Swedish referral centers. PATIENTS: Patients with craniopharyngioma (n = 177) with available data on bone health after a median follow-up of 16 years (range, 1-62) were included (106 [60%] Dutch, 93 [53%] male, 84 [48%] childhood-onset disease). MAIN OUTCOME MEASURES: Fractures, dual X-ray absorptiometry-derived bone mineral density (BMD), and final height were evaluated. Low BMD was defined as T- or Z-score ≤-1 and very low BMD as ≤-2.5 or ≤-2.0, respectively. RESULTS: Fractures occurred in 31 patients (18%) and were more frequent in men than in women (26% vs. 8%, P = .002). Mean BMD was normal (Z-score total body 0.1 [range, -4.1 to 3.5]) but T- or Z-score ≤-1 occurred in 47 (50%) patients and T-score ≤-2.5 or Z-score ≤-2.0 in 22 (24%) patients. Men received less often treatment for low BMD than women (7% vs. 18%, P = .02). Female sex (OR 0.3, P = .004) and surgery (odds ratio [OR], 0.2; P = .01) were both independent protective factors for fractures, whereas antiepileptic medication was a risk factor (OR, 3.6; P = .03), whereas T-score ≤-2.5 or Z-score ≤-2.0 was not (OR, 2.1; P = .21). Mean final height was normal and did not differ between men and women, or adulthood and childhood-onset patients. CONCLUSIONS: Men with craniopharyngioma are at higher risk than women for fractures. In patients with craniopharyngioma, a very low BMD (T-score ≤-2.5 or Z-score ≤-2.0) seems not to be a good predictor for fracture risk.
引用
- van Santen SS, Olsson DS, van den Heuvel-Eibrink MM, et al. Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years. J Clin Endocrinol Metab. 2020. PMID: 32145029. doi:10.1210/clinem/dgz279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。